Literature DB >> 21525953

Self-inactivating helper virus for the production of high-capacity adenoviral vectors.

M Gonzalez-Aparicio1, I Mauleon, P Alzuguren, M Bunuales, G Gonzalez-Aseguinolaza, C San Martín, J Prieto, R Hernandez-Alcoceba.   

Abstract

Standard methods for producing high-capacity adenoviral vectors (HC-Ads) are based on co-infection with a helper adenovirus (HV). To avoid HV encapsidation, its packaging signal (Ψ) is flanked by recognition sequences for recombinases expressed in the producing cells. However, accumulation of HV and low yield of HC-Ad are frequently observed, due in part to insufficient recombinase expression. We describe here a novel HV (AdTetCre) in which Ψ is flanked by loxP sites that can be excised by a chimeric MerCreMer recombinase encoded in the same viral genome. Efficient modulation of cleavage was obtained by simultaneous control of MerCreMer expression using a tet-on inducible system, and translocation to the nucleus by 4-hydroxytamoxifen (TAM). Encapsidation of AdTetCre was strongly inhibited by TAM plus doxycicline. Using AdTetCre and 293Cre4 cells for the production of HC-Ads, we found that cellular and virus-encoded recombinases cooperate to minimize HV contamination. The method was highly reproducible and allowed the routine production of different HC-Ads in a medium-scale laboratory setting in adherent cells, with titers >10¹⁰ infectious units and <0.1% HV contamination. The residual HVs lacked Ψ and were highly attenuated. We conclude that self-inactivating HVs based on virally encoded recombinases are promising tools for the production of HC-Ads.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525953     DOI: 10.1038/gt.2011.58

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

1.  Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.

Authors:  J Poutou; M Bunuales; M Gonzalez-Aparicio; E Garcia-Aragoncillo; J I Quetglas; R Casado; C Bravo-Perez; P Alzuguren; R Hernandez-Alcoceba
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

2.  Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors.

Authors:  P Fernandes; D Simão; M R Guerreiro; E J Kremer; A S Coroadinha; P M Alves
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

Review 3.  Immunological landscape and immunotherapy of hepatocellular carcinoma.

Authors:  Jesús Prieto; Ignacio Melero; Bruno Sangro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

4.  Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.

Authors:  C Unzu; I Melero; S Hervás-Stubbs; A Sampedro; U Mancheño; A Morales-Kastresana; I Serrano-Mendioroz; R E de Salamanca; A Benito; A Fontanellas
Journal:  Gene Ther       Date:  2015-07-23       Impact factor: 5.250

5.  Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.

Authors:  Paulo Fernandes; Ana I Almeida; Eric J Kremer; Paula M Alves; Ana S Coroadinha
Journal:  Sci Rep       Date:  2015-03-16       Impact factor: 4.379

6.  Localization of adenovirus morphogenesis players, together with visualization of assembly intermediates and failed products, favor a model where assembly and packaging occur concurrently at the periphery of the replication center.

Authors:  Gabriela N Condezo; Carmen San Martín
Journal:  PLoS Pathog       Date:  2017-04-27       Impact factor: 6.823

7.  Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.

Authors:  Cody S Lee; Elliot S Bishop; Ruyi Zhang; Xinyi Yu; Evan M Farina; Shujuan Yan; Chen Zhao; Zongyue Zheng; Yi Shu; Xingye Wu; Jiayan Lei; Yasha Li; Wenwen Zhang; Chao Yang; Ke Wu; Ying Wu; Sherwin Ho; Aravind Athiviraham; Michael J Lee; Jennifer Moriatis Wolf; Russell R Reid; Tong-Chuan He
Journal:  Genes Dis       Date:  2017-04-27

Review 8.  High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Authors:  Ana Ricobaraza; Manuela Gonzalez-Aparicio; Lucia Mora-Jimenez; Sara Lumbreras; Ruben Hernandez-Alcoceba
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 9.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

10.  Danio Rerio as Model Organism for Adenoviral Vector Evaluation.

Authors:  Paola Gulías; Jorge Guerra-Varela; Manuela Gonzalez-Aparicio; Ana Ricobaraza; Africa Vales; Gloria Gonzalez-Aseguinolaza; Rubén Hernandez-Alcoceba; Laura Sánchez
Journal:  Genes (Basel)       Date:  2019-12-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.